Defeasance Provisions definition
Defeasance Provisions. As set forth in the Indenture.
Defeasance Provisions. As described in the Prospectus Supplement dated January 21, 2003.
Defeasance Provisions. The defeasance and covenant defeasance provisions of the Indenture will apply to the Designated Securities.
Examples of Defeasance Provisions in a sentence
Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II, such other terms are specified in the Pricing Prospectus.
Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II-2, such other terms are specified in the Pricing Prospectus.
Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II-1, such other terms are specified in the Pricing Prospectus.
Defeasance Provisions: As described in the Basic Prospectus dated February 26, 2018.
On-Sale Clauses; Assumption Agreements; Defeasance Provisions SECTION 3.10.
More Definitions of Defeasance Provisions
Defeasance Provisions. Subject to the defeasance and covenant defeasance provisions of Article 15 of the Indenture, dated as of June 1, 1986, between the Company and The Chase Manhattan Bank (formerly Chemical Bank, successor by merger to Manufacturers Hanover Trust Company), as Trustee.
Defeasance Provisions. Defeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. December 20, 2016, at 9:00 a.m. (New York City time) at the offices of ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇.
Defeasance Provisions. As set forth in the Indenture. GUARANTORS: Brandywine Realty Trust and the Subsidiary Guarantors named in the Prospectus Supplement dated the date hereof relating to the Designated Securities.
Defeasance Provisions. The provisions of Article 14 of the Indenture relating to defeasance and covenant defeasance will apply to the Notes.
Defeasance Provisions. As described in the Prospectus Supplement dated June 6, 2002.
Defeasance Provisions. Defeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. May 20, 2022, at 9:00 a.m. (New York City time) at the offices of ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇. As to the 2027 Notes, the 2029 Notes, the 2032 Notes, the 2052 Notes and the 2062 Notes (and designated to act on behalf of the other Underwriters or other Representatives): BofA Securities, Inc. ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ Attention: High Grade Debt Capital Markets Transaction Management/Legal Barclays Capital Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Attention: Syndicate Registration Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ Deutsche Bank Securities Inc. ▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ Attention: Debt Capital Markets Syndicate ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co. LLC ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Fax No.: (▇▇▇) ▇▇▇-▇▇▇▇ Attention: Investment Banking Division RBC Capital Markets, LLC ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, 8th Floor New York, New York 10281 Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ Attention: USDCM Transaction Management U.S. Bancorp Investments, Inc. ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, 26th Floor Charlotte, North Carolina 28202 Attention: Debt Capital Markets Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ • Final term sheet, dated May 17, 2022 relating to the 2027 Notes, the 2029 Notes, the 2032 Notes, the 2052 Notes and the 2062 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings (Moody’s / S&P / Fitch)*: [Intentionally Omitted] Note Type: SEC Registered (No. 333-236600) Trade Date: May 17, 2022 Settlement Date (T+3): May 20, 2022 Maturity Date: May 15, 2027 (the “2027 Notes”) May 15, 2029 (the “2029 Notes”) May 15, 2032 (the “2032 Notes”) May 15, 2052 (the “2052 Notes”) May 15, 2062 (the “2062 Notes”) Principal Amount Offered: $600,000,000 (2027 Notes) $900,000,000 (2029 Notes) $1,500,000,000 (2032 Notes) $2,000,000,000 (2052 Notes) $1,000,000,000 (2062 Notes) Price to Public (Issue Price): 99.946% (2027 Notes) 99.639% (2029 Notes) 99.742% (2032 Notes) 99.100% (2052 Notes) 99.020% (2062 Notes) Net Proceeds (Before Expenses) to Issuer: $597,576,000 (99.596%) (2027 Notes) $893,151,000 (99.239%) (2029 Notes) $1,489,380,000 (99.292%) (2032 Notes) $1,967,000,000 (98.350%) (2052 Notes) $982,200,000 (98.220%) (2062 Notes) Interest Rate: 3.700% (2027 Notes) 4.000% (2029 Notes) 4.200% (2032 Notes) 4.750% (2052 Notes) 4.950% (2062 Notes) Interest Payme...
Defeasance Provisions. Defeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. February 17, 2011, at 9:00 a.m., New York City time, at the offices of ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ As to the 2021 Notes and the 2041 Notes (and designated to act on behalf of the other Underwriters or other Representatives): Barclays Capital Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: Syndicate Registration Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ Deutsche Bank Securities Inc. ▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: Debt Capital Markets Syndicate Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ UBS Securities LLC ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: Fixed Income Syndicate Facsimile: ▇▇▇-▇▇▇-▇▇▇▇ ▇▇▇▇▇ Fargo Securities, LLC ▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attention: Transaction Management Facsimile: ▇▇▇-▇▇▇-▇▇▇▇ • Final term sheet, dated February 14, 2011, relating to the 2021 Notes and the 2041 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings: [Intentionally omitted] Note Type: SEC Registered (No. 333-172235) Trade Date: February 14, 2011 Settlement Date (T+ 3): February 17, 2011 Title of Securities 4.70% Notes Due February 15, 2021 (“2021 Notes”) 5.95% Notes Due February 15, 2041 (“2041 Notes”) Maturity Date: February 15, 2021 (2021 Notes) February 15, 2041 (2041 Notes) Principal Amount Offered: $400,000,000 (2021 Notes) $350,000,000 (2041 Notes) Price to Public (Issue Price): 99.819% (2021 Notes) 99.474% (2041 Notes) Interest Rate: 4.70% (2021 Notes) 5.95% (2041 Notes) Interest Payment Dates: February 15 and August 15, commencing August 15, 2011 Benchmark: 3.625% due 02/15/21 (2021 Notes) 4.250% due 11/15/40 (2041 Notes) Benchmark Yield: 3.623% (2021 Notes) 4.688% (2041 Notes) Spread to Benchmark: 110 basis points (2021 Notes) 130 basis points (2041 Notes) Re-offer Yield: 4.723% (2021 Notes) 5.988% (2041 Notes)